Early outcomes of abbreviated multi-fractionated brachytherapy schedule for cervix cancer during COVID-19 pandemic

PURPOSE: Brachytherapy (BT) for cervix cancer was listed as a level I priority and reduced number of implants and multiple fractions were recommended during COVID-19 pandemic. We present early clinical outcome of this approach. METHODS AND MATERIALS: Patients treated with (chemo)radiotherapy and BT...

Descripción completa

Detalles Bibliográficos
Autores principales: Chopra, Supriya, Mulani, Jaahid, Mittal, Prachi, Singh, Maneesh, Shinde, Amruta, Gurram, Lavanya, Scaria, Libin, Aravindakshan, Dheera, Kohle, Satish, Rane, Priyanka, Ghadi, Yogesh, Rath, Sushmita, Ghosh, Jaya, Gulia, Seema, Gupta, Sudeep, Kinhikar, Rajesh, Laskar, Sarbani, Agarwal, Jai Prakash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Brachytherapy Society. Published by Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626438/
https://www.ncbi.nlm.nih.gov/pubmed/36585283
http://dx.doi.org/10.1016/j.brachy.2022.10.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626438/
https://www.ncbi.nlm.nih.gov/pubmed/36585283
http://dx.doi.org/10.1016/j.brachy.2022.10.006

Ejemplares similares